Alzheimer’s disease neuroimaging includes structural and functional magnetic resonance imaging (MRI) [7], fluorodeoxyglucose PET, and Aβ and tau PET uptake [7,8]. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.